The Preventive and Curative Effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on Immobilization Stress-Induced Anxiety/Depression and Colitis in Mice
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The gut dysbiosis by stressors such as immobilization deteriorates psychiatric disorders through microbiota-gut-brain axis activation. To understand whether probiotics could simultaneously alleviate anxiety/depression and colitis, we examined their effects on immobilization stress (IS)-induced anxiety/depression and colitis in mice. The probiotics Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 were isolated from healthy human feces. Mice with anxiety/depression and colitis were prepared by IS treatment. NK33 and NK98 potently suppressed NF-κB activation in lipopolysaccharide (LPS)-induced BV-2 cells. Treatment with NK33 and/or NK98, which were orally gavaged in mice before or after IS treatment, significantly suppressed the occurrence and development of anxiety/depression, infiltration of Iba1+ and LPS+/CD11b+ cells (activated microglia) into the hippocampus, and corticosterone, IL-6, and LPS levels in the blood. Furthermore, they induced hippocampal BDNF expression while NF-κB activation was suppressed. NK33 and/or NK98 treatments suppressed IS-induced colon shortening, myeloperoxidase activity, infiltration of CD11b+/CD11c+ cells, and IL-6 expression in the colon. Their treatments also suppressed the IS-induced fecal Proteobacteria population and excessive LPS production. They also induced BDNF expression in LPS-induced SH-SY5Y cells in vitro. In conclusion, NK33 and NK98 synergistically alleviated the occurrence and development of anxiety/depression and colitis through the regulation of gut immune responses and microbiota composition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Oral administration of Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 attenuated IS-induced anxiety/depression and hippocampal inflammation in mice. (A) Procedure. Effects on anxiety/depression-like behaviors in elevated plus maze (B: (a), OT; (b), OE), LDT (C: (a), TL; (b), NT), tail suspension (D), and forced swimming (E) tasks. (F) Effects on hippocampal BDNF expression, and CREB and NF-κB activation. Effects on the infiltration of LPS+/CD11b+ (G) and Iba1+ cells (H) into the hippocampus. Effects on blood corticosterone (CORT, I), IL-6 (J), and LPS levels (K). Mice were exposed to IS and test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days. Normal control group (NC), not exposed to IS, was treated with 1% maltose instead of test agents. Hippocampal p65, p-p65, CREB, p-CREB, BDNF, and β-actin were analyzed by immunoblotting. Blood IL-6, corticosterone, and LPS were assayed by ELISA kits. Iba1+ and LPS+/CD11b+ cells were measured using a confocal microscope. Data values were indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS alone treated group.](https://figures.cochat.ai/paper-figures/f295618ef0d346b6ab344642211ff120/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-2.jpg)
![Figure 3 Oral administration of Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 alleviated immobilization stress (IS)-induced colitis in mice. Effects on the colon length (A), macroscopic score (B), myeloperoxidase (MPO) activity (C), IL-6 (D), IL-1β (E), and COX-2 expression, and NF-κB activation (F). Effects on the infiltration of CD11b+/CD11c+ cells into the colon (G), fecal microbiota composition (H), and fecal LPS levels (I). First, mice were exposed to IS and test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days. Normal control group (NC), not exposed to IS, was treated with 1% maltose instead of test agents. Colonic p65, p-p65, COX-2, and β-actin were analyzed by immunoblotting. CD11b+ and CD11c+ cell populations were assayed using a confocal microscope. Fecal bacteria were assayed by qPCR. Fecal LPS assayed by ELISA kit. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/3a3ce012da5a43928f619d4fe82acd97/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-3.jpg)
![Figure 4 Pretreatment with Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 protected IS-induced anxiety and hippocampal inflammation in mice. (A) Procedure. Effects on anxiety-like behaviors in elevated plus maze (B: (a), OT; (b), OE), LDT (C: (a), TL; (b), NT), tail suspension (D), and forced swimming (E) tasks. (F) Effects on hippocampal BDNF expression and CREB and NF-κB activation. Effects on the infiltration of LPS+/CD11b+ (G) and Iba1+ cells (H) into the hippocampus. Effects on blood corticoterone (CORT, I), IL-6 (J), and LPS levels (K). Test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days and IS then exposed to mice. Normal control group (NC), not exposed to IS, were treated with 1% maltose instead of test agents. Hippocampal p65, p-p65, CREB, p-CREB, BDNF, and β-actin were assayed by immunoblotting. Blood corticosterone, IL-6, and LPS were assayed by ELISA kits. Iba1+ and LPS+/CD11b+ cells were measured using a confocal microscope. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/3ea3e24b41f3415eb8670cfd52bb7f70/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-4.jpg)
![Figure 5 Pretreatment with Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 protected IS-induced colitis in mice. Effects on colon length (A), macroscopic score (B), colonic myeloperoxidase (MPO) activity (C), IL-6 (D), IL-1β (E), and COX-2 expression and NF-κB activation (F). (G) Effects on the CD11b+/CD11c+ cell infiltration into the colon. Effects on fecal microbiota composition (H) and fecal LPS levels (I). Test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days and IS then exposed to mice. Normal control group (NC), not exposed to IS, were treated with 1% maltose instead of test agents. Colonic p65, p-p65, COX-2, and β-actin were analyzed by immunoblotting. CD11b+ and CD11c+ cells were assayed using a confocal microscope. Fecal bacteria were assayed by qPCR. Fecal LPS were assayed by ELISA kit. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/c1e4fc9b795244b2a30511a68364aa22/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“such a treatment decreased the Proteobacteria population and bacterial LPS production in murine gut.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [130]
In the citing paper
“Jang et al. [130] showed that oral administration of the probiotics Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 isolated from healthy human feces suppressed the immobilization stress-induced anxiety and depression in mice.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · cited 2×
“However, the fecal transplantation of conventional mice into germ-free mice suppresses anxiety [19].”
BackgroundThe gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“The gut microbiota is bidirectionally connected to the brain: Dysfunction of the HPA axis by stressors can cause gut microbiota dysbiosis and psychiatric disorders and probiotics can alleviate anxiety [47,48].”
BackgroundThe role of the gut microbiota in nutrition and health
Flint, H. J., Scott, K. P., Louis, P., & Duncan, S. H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.156 · Cited by 2,182
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · cited 1×
“Anxiety disorder is the most common disorder characterized by somatic, emotional, cognitive, and behavioral components [1,2].”
BackgroundMechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423 · cited 1×
“Probiotics, including bifidobacteria and lactobacilli, exhibit a variety of pharmacological activities: They alleviate constipation, diarrhea, imbalanced immune system, and psychiatric disorders [22,23].”
BackgroundKim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., & Kim, D.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,176 · cited 1×
“The endotoxin concentrations of feces and blood were assayed, as previously reported [31].”
MethodSelf-citation
Cited by
Items 101–200 of 208
BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
Laha, S., Katheeja Muhseena, N., Das, S. P., & Das, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1035052 · Cited by 24
Zhou, C., Chen, Y., Xue, S., Shi, Q., Guo, L., Yu, H., Xue, F., Cai, M., Wang, H., & Peng, Z. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14287 · Cited by 18
“74,75 Together, intestinal dysbacteriosis might be a common pathogenesis both in anxiety and depression.”
BackgroundGîlcă-Blanariu, G.-E., Șchiopu, C. G., Ștefănescu, G., Mihai, C., Diaconescu, S., Afrăsânie, V. A., Lupu, V. V., Lupu, A., Boloș, A., & Ștefănescu, C. (2023) · Microorganisms · doi:10.3390/microorganisms11092268 · Cited by 20
“Lactobacillus reuteri (mice) Decreased inflammatory activity in colitis Improvement in anxiety behavior Improvement in depressive symptoms [47]”
BackgroundTao, W., Zhang, Y., Wang, B., Nie, S., Li, F., Xiao, J., & Wu, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.023 · Cited by 22
Lee, D.-Y., Baek, J.-S., Shin, Y.-J., & Kim, D. H. (2024) · Nutrients · doi:10.3390/nu16213711 · Cited by 23
“For the immunofluorescence staining, mice were transcardially perfused, as previously reported [13].”
InfluentialSelf-citationLi, S., Qian, Q., Xie, Y., Wu, Z., Yang, H., Yin, Y., Cui, Y., & Li, X. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c03039 · Cited by 20
Li, B., Wang, H., Wang, M., Liang, H., Hu, T., Yang, J., Li, S., You, X., Xia, B., Yuan, Y., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1496280 · Cited by 22
Add-on probiotics for inflammatory depression – A double-blind randomized placebo-controlled trial
Veibäck, G. S., Lindahl, J., Suneson, K., Tjernberg, J., Ståhl, D., Landberg, R., Asp, M., Kjellberg, A., Falknäs, F., Sjöberg, K., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.002 · Cited by 24
Zhao, H., Chen, X., Zhang, L., Tang, C., Meng, F., Zhou, L., Ping, Z., Lu, Z., & Lu, Y. (2023) · Food & Function · doi:10.1039/d2fo04014j · Cited by 22
Murakami, H., Ko, T., Ouchi, H., Namba, T., Ebihara, S., & Kobayashi, S. (2024) · Nutrients · doi:10.3390/nu16111702 · Cited by 19
Supplementation of Lactobacillus early in life alters attention bias to threat in piglets
Verbeek, E., Dicksved, J., & Keeling, L. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-89560-2 · Cited by 21
Probiotics for the Chemoprotective Role against the Toxic Effect of Cancer Chemotherapy
Waziri, A., Bharti, C., Aslam, M., Jamil, P., Mirza, M. A., Javed, M. N., Pottoo, U., Ahmadi, A., & Alam, M. S. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210514000615 · Cited by 24
Ruohan, Z., Ruting, W., Hongxi, W., Zhenjin, H., Jiale, L., Rongxin, Z., Jiang, F., & Yuanbo, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1664800 · Cited by 19
Therapeutic Implications of the Microbial Hypothesis of Mental Illness
Savitz, J. B., & Yolken, R. H. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_368 · Cited by 16
Advances in the study of the effects of gut microflora on microglia in Alzheimer’s disease
Wu, J.-J., & Wei, Z. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1295916 · Cited by 18
Cen, Q., Cui, Y., Feng, J., Li, Z., Wei, J., Wang, L., Chang, C., Pang, R., Wang, J., & Zhang, A. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10545-y · Cited by 20
“Oral L. reuteri NK33 or NK98 administration attenuates microglial cell infiltration and exerts neuroprotective effects by inhibiting NF-κB activation and promoting BDNF expression in a mouse anxiety/ depression model [23].”
Li, J., Wan, B., Zhou, L., Qian, X., Wang, F., Gu, S., Ma, X., & Huang, J. H. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1629182 · Cited by 27
“For instance, Lactobacillus reuteri has been shown to ameliorate anxiety-and MDD-like behaviors in mice by reducing microglial hyperactivation (61, 62).”
Zhang, L., Zhang, S., Jiang, M.-Z., Ni, X., Du, M., Jiang, H., Bi, M., Wang, Y., Liu, C. X., & Liu, S. (2024) · Nutrients · doi:10.3390/nu16183209 · Cited by 16
“Specifically, Lm. reuteri NK33 was applied for the prevention and medication of anxiety/depression, where it reduced the levels of corticosterone, IL-6, and LPS in the blood and introduced the infiltration of Iba1 + and LPS + /CD11b + cells (activated microglia) into the hippocampus [13].”
MethodLi, Y., Wu, B., Li, X., Qin, Z., Yang, X., & Li, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.751791 · Cited by 15
“The efficacy of depressive symptoms was evaluated by Jang et al. (2019).”
BackgroundThe Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge
Xu, M., Zhang, Z., Zhang, Z., Liu, D., Shang, Y., Tang, C., Wang, W., Li, H., You, B., Ying, H., et al. (2025) · Neurology International · doi:10.3390/neurolint17080120 · Cited by 20
“Probiotics (e.g., B. infantis CCFM687, L. reuteri NK33, B. adolescentis NK98) reverse HPA overactivation and inflammation [104–106].”
Zhao, X., Xu, M., Zhao, Z., Wang, Y., Liu, Y., Zhang, T., Wan, X., Jiang, M., Luo, X., Shen, Y., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14165 · Cited by 16
Gut bacteria: an etiological agent in human pathological conditions
Islam, M. M., Mahbub, N. U., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1291148 · Cited by 18
“Lactobacillus reuteri NK33 and Bi fi dobacterium adolescentis NK98 alleviate stress, depression, anxiety, and sleep disturbances through the suppression of in fl ammation, improvement of the gut ecosystem and increased brain-derived neurotrophic factor expression (Jang et al., 2019).”
BackgroundYun, S.-W., Shin, Y.-J., Ma, X., & Kim, D. (2024) · Nutrients · doi:10.3390/nu16223810 · Cited by 14
Self-citationMa, X., Yoo, J.-W., Shin, Y.-J., Park, H.-S., Son, Y.-H., & Kim, D. (2023) · Nutrients · doi:10.3390/nu15051068 · Cited by 19
“Periodontal, colon, and brain tissues were treated with RIPAL buffer and centrifuged (10,000× g, 4 ◦C, 10 min), as previously reported [23].”
MethodSelf-citationZheng, Q., Wang, S., Tian, X.-Y., Liu, W., & Gao, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1203015 · Cited by 18
“As a type of probiotic, there is a popular belief that Lactobacillus is beneficial to improve depression syndrome (55, 56).”
BackgroundChang, W., Guo, J., Yang, Y., Zou, L., Fu, Y., Li, M., Li, L., Li, C., Wang, X., Zhao, X., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4475 · Cited by 16
Ma, X., Shin, J.-W., Cho, J., Han, S.-W., & Kim, D. (2023) · Letters in Applied Microbiology · doi:10.1093/lambio/ovad144 · Cited by 20
Self-citationGhannoum, M. A., Long, L. A., Bunick, C. G., Rosso, J. Q. D., Gamal, A., Tyring, S. K., McCormick, T. S., & Grada, A. A. (2022) · Antibiotics · doi:10.3390/antibiotics11030324 · Cited by 15
“These probiotic bacteria are reported to have antidepressant effects [29,30], modulate the immune response [31], and reduce harmful gut colonization by direct inhibition of competing pathogens.”
BackgroundMaturation, Morphology, and Function: The Decisive Role of Intestinal Flora on Microglia: A Review
Liu, L., Tong, F., Li, H., Bin, Y., Ding, P., Peng, L., Liu, Z., & Dong, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203070 · Cited by 14
“Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 were found to ameliorate restraint-induced stress anxiety/depression in mice [103].”
BackgroundMi, Y., Chen, K., Lin, S., Tong, L., Zhou, J., & Wan, M. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00387-z · Cited by 12
“For example, one study showed that oral administration of Lactobacillus reuteri NK33 could inhibit the development of anxiety and depression [64].”
InfluentialWang, Q., Deng, Z., Lan, J., Li, D., Fan, K., Chang, J., & Ma, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911210 · Cited by 13
“casei could also alleviate stress and anxiety in humans and mice through the regulation of gut immune responses and microbiota composition [41,42].”
BackgroundCho, H., Jo, M., Oh, H., Lee, Y., & Park, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109326 · Cited by 12
Manna, L., Rizzi, E., Bafile, E., Cappelleri, A., Ruscica, M., Macchi, C., Vulpiani, M. P., Salini, R., Rossi, E., Panebianco, C., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1072334 · Cited by 13
“, Bifidobacterium longum (16), Lactococcus lactis (17), Lactobacillus plantarum (recently reclassified as Lactiplantibacillus plantarum) (18), Lactobacillus reuteri (recently renamed Limosilactobacillus reuteri) (19) have been reported to modulate the gut microbiota composition leading to a restored intestinal barrier…”
BackgroundThe interplay between the microbiota and opioid in the treatment of neuropathic pain
Gong, Z., Xue, Q., Luo, Y., Yu, B., Hua, B., & Liu, Z. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1390046 · Cited by 12
Liu, Q., Ding, P., Zhu, Y. J., Wang, C., Yin, L., Zhu, J., Nie, S., Wang, S., Zheng, C., Shen, H., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137394 · Cited by 13
Efficacy of bifidobacterium-related preparations on depression: the first meta-analysis
Huang, R., & Liu, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1463848 · Cited by 13
Zhang, C., Wang, L., Liu, X., Wang, G., Zhao, J., & Chen, W. (2024) · Food & Function · doi:10.1039/d4fo04660a · Cited by 11
Mo, X., Guo, S., He, D., Cheng, Q., Yang, Y., Wang, H., Ren, Y., Liu, L., & Xie, P. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00739-8 · Cited by 10
Sulfuretin exerts anti-depressive effects in the lipopolysaccharide-induced depressive mouse models
Sun, X., Jiang, X., Li, X., Qi, Z., & Lu, Y. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113800 · Cited by 10
Wang, S., Li, B., Tan, H., Sun, X., Tian, J., Li, S., Xu, Y., Bian, Y., & Wang, Y. (2024) · Food Frontiers · doi:10.1002/fft2.482 · Cited by 8
The role of gut microbiota in adolescent depression: Insights from adverse childhood experiences
Bai, Y., Shu, C., Zhang, S., Gui, G., Zhang, R., Yu, S., Dong, C., Duan, R., Ai, X., Liu, R., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120141 · Cited by 8
Xu, L., Li, Y., & He, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1237256 · Cited by 10
Baek, J.-S., Lee, D.-Y., Han, S.-W., & Kim, Y. (2024) · Letters in Applied Microbiology · doi:10.1093/lambio/ovae065 · Cited by 8
Microglia and Microbiome-Gut-Brain Axis
Filho, A. M. C., Gomes, N. S., Lós, D. B., Leite, I. B., Tremblay, M., & Macêdo, D. S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_17 · Cited by 8
Doenyas, C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01167-3 · Cited by 9
“Additionally, treatments targeting the gut microbiota have emerged with promising evidence for their effectiveness in improving anxiety and depression (Capuco et al. 2020; Jang et al. 2019), ASD-related symptoms (Kang et al.”
BackgroundSasaki, H., Masutomi, H., Nakamura, S., Tanigawa, C., Cui, Y., Ishihara, K., Yanagisawa, M., & Kokubo, T. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1551313 · Cited by 8
Fan, Y., Gu, X., Yang, H., Chen, Y., Fang, C., Deng, H., & Dai, L. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00376-2 · Cited by 10
Yang, J., Zhou, G., Ou, Z., Jia, N., & Wang, D. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/3567447 · Cited by 8
RetractedJin, D., Lv, T., Zhang, C.-Y., & Hu, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-13699-8 · Cited by 6
“Emerging research indicates that certain strains of probiotics, particularly those within the Lactobacillus and Bifidobacterium genera, may influence mood regulation and help alleviate depressive symptoms [56, 57].”
Babaei, F. G., Moghimi, A., Saburi, E., Makhdoumi, A., & Rassouli, M. B. (2025) · Brain and Behavior · doi:10.1002/brb3.70814 · Cited by 5
Yao, H., Guo, W., Suo, L.-L., Li, G., Wang, Y.-S., Chen, Y., Sun, Y., & Ding, R. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113813 · Cited by 6
Wei, R., Chen, Z., Chen, S., Wang, J., Zeng, Z., Lin, L., Sun, Z., Ji, L., & Li, Y. (2023) · Journal of Food Science · doi:10.1111/1750-3841.16616 · Cited by 6
Probiotic Mechanism to Modulate the Gut-Brain Axis (GBA)
Samtiya, M., Dhewa, T., & Puniya, A. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_10 · Cited by 13
Shin, Y.-J., Ma, X., Baek, J.-S., & Kim, D.-H. (2025) · Microorganisms · doi:10.3390/microorganisms13040955 · Cited by 5
“Depression and anxiety-like behaviors were assessed utilizing the open field test (OFT), elevated plus maze task (EPMT), and tail suspension test (TST) [21,25].”
Self-citationKaur, S., Jangli, A., Giridharan, V. V., & Dandekar, M. P. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107615 · Cited by 8
Enwere, M., Irobi, E., Onu, A., Davies, E., Ogungbade, G. O., Omoniwa, O., Omale, C., Neufeld, M., Chime, V., Ezeogu, A., et al. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7040062 · Cited by 6
“Synbiotic approaches may amplify effects: B. infantis combined with xylooligosaccharide or psyllium further increased IL-10 and tight junction expression [126].”
InfluentialBaek, J.-S., Ma, X., Park, H.-S., Lee, D.-Y., & Kim, D.-H. (2025) · Cells · doi:10.3390/cells14191547 · Cited by 8
“Tissue samples were then processed for immunofluorescence staining according to previously established protocols [29].”
InfluentialSelf-citationPal, S., Arisha, R., & Mazumder, P. M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03332-z · Cited by 5
Zhang, S., Shang, K., Gong, L., Xie, Q., Sun, J., Xu, M. M., Wei, X., Xie, Z., Liu, X., Tang, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202500882 · Cited by 9
Yun, S.-W., Lee, D.-Y., Park, H.-S., & Kim, D.-H. (2024) · Nutrients · doi:10.3390/nu16162736 · Cited by 6
“BV2 cells (Korea Cell Line Bank, Seoul, Republic of Korea) were cultured in DMEM containing 1% antibiotic–antimycotic and 5% fetal bovine serum at 37 ◦ C, as previously reported [23].”
MethodSelf-citationTang, Y., Guo, Y., Xie, X., Chen, Y., Huang, X., Dai, D., & Wu, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1563329 · Cited by 4
Hu, S., Li, L., Zhou, C., Zhang, Y., & Yu, X. (2025) · Nutrients · doi:10.3390/nu17121955 · Cited by 5
Luo, K., Xing, Y., & Wang, M. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122980 · Cited by 4
Kim, K., Song, J., Yang, S.-J., Choi, J.-W., Sohn, J., Han, S., Shin, Y.-J., Lee, D.-Y., Lee, S., & Kim, D. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2021.k.0103 · Cited by 4
Self-citationHu, S., Zhou, C., Zhang, Y., Li, L., & Yu, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104760 · Cited by 3
Ye, L., Peng, L., Tian, J., & Ma, H. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1698851 · Cited by 4
Microbiota-driven gut-brain signaling underlies antidepressant effects of a GLP-1 analog
Bian, L., Cai, Y., Zhang, Y., Shen, L., Wang, H., Gao, F., Cai, N., Chen, W., You, C., Yang, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.003 · Cited by 4
Therapeutic Mechanisms of Gut Microbiota and Probiotics in the Management of Mental Disorders
Yadav, M., Kumar, A., & Shandil, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_3 · Cited by 4
Current Insights into the Use of Probiotics and Fatty Acids in Alleviating Depression
Gao, H., He, C., Xin, S., Hua, R., Du, Y., Wang, B., Gong, F., Yu, X., Pan, L., Gao, L., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11082018 · Cited by 3
Chang, W.-Y., Qin, Q., Li, X., Wang, J.-J., Chen, Y., Ruan, H., Qu, Y., Jiang, X., & He, H. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i6.104809 · Cited by 5
An Overview of Dairy Microflora
Baig, D. N., & Mehnaz, S. (2021) · Microorganisms for sustainability · doi:10.1007/978-981-16-0223-8_4 · Cited by 4
Gu, C. J., Xu, R., Yin, B., Wu, R., Wei, Y., Wang, D., & Wei, W. (2025) · Integrative Zoology · doi:10.1111/1749-4877.13014 · Cited by 4
Peng, L., Zhang, Z., Hu, Y., Chen, H., Tian, Y., & Ling, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1706811 · Cited by 2
Lindahl, J., Veibäck, G. S., Suneson, K., Blanking, W., Tjernberg, J., Ståhl, D., Wiman, Å., Ventorp, F., Erhardt, S., & Lindqvist, D. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101221 · Cited by 3
“While there is some preclinical evidence suggesting an anti-inflammatory and KP-modulating effect of L . reuteri (Han et al., 2020; Jang et al., 2019; Lee et al., 2023; Schwarcz et al., 2024) our clinical results generally did not support this.”
Kisaka, Y., Yamamoto, M., Yanase, K., Sakurai, K., Eguchi, A., Watanabe, M., Mori, C., Todaka, E., & and the Japan Environment and Children's Study (JECS) Group (2025) · Research in Nursing & Health · doi:10.1002/nur.22442 · Cited by 3
Homeostatic regulation of neuronal excitability by probiotics in male germ‐free mice
Kim, J., Kim, D. W., Lee, A. C., Mason, M., Jouroukhin, Y., Woo, H., Yolken, R. H., & Pletnikov, M. V. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24999 · Cited by 2
“Probiotics are also known to decrease anxiety in several preclinical mouse models including BALB/c mice characterized by elevated anxiety (BarrosSantos et al., 2020; Han & Kim, 2019; Jang et al., 2019; Murray et al., 2019, 2020; Savignac et al., 2014, 2015; Surzenko et al., 2020).”
BackgroundSelf-citationA INTRÍNSECA RELAÇÃO DA MICROBIOTA INTESTINAL COM A SAÚDE MENTAL
Moura, M. M. D. A., Mendonça, M. A., Novaes, M. R. L., de Sousa, M. R., & dos Santos, M. S. (2023) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v9i3.8704 · Cited by 9
Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Rodríguez‐Landa, J. F., Jaime, H. B., Limón‐Morales, O., Muñoz‐Carrillo, J. L., Pérez-Vega, M. I., & Soria-Fregozo, C. (2026) · Nutrients · doi:10.3390/nu18050713 · Cited by 1
“…and Lactobacillus rhamnosus have suggested that their anxiolytic-like effects may be mediated, at least in part, by anti-inflammatory mechanisms [48] as well as by HPA axis regulation and the modulation of neurochemical systems, including increased serotonin and BDNF levels in the brain [49].”
Huang, J., Jiang, Y., Zou, Z., Qian, Z., Su, Y., Liu, L., Sun, W., Chen, J., Li, L., Du, B., et al. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c00317 · Cited by 1
Oral probiotic delivery-based therapeutic strategies for inflammatory bowel disease
Li, S., Deng, H., Fu, S., Li, J., Luo, X., Chen, Z., Wang, P., Feng, X., Chen, Y., Fu, C., et al. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101187 · Cited by 2
“Recent research highlights the significant influence of gut dysbiosis on neuropsychiatric disorders, especially anxiety and depression, which are often associated with IBD [ 138 ].”
Teixeira, L. L., de Oliveira, B. I. A., Silva, C. M. O. E., Cançado, G. B. D. P., Veloso, G. M. V., Paula, M. M. D. M., de Souza, T. S., & Leite, N. A. A. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n2-060 · Cited by 3
Chen, J., Zhu, X., Yang, P., Liu, H., Wu, H., & Zhou, C. (2023) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-023-1366-4 · Cited by 1
Use of FISH‐FLOW as a Method for the Identification and Quantification of Bacterial Populations
Bucheli, J. E. V., Lee, Y., Kim, B., Azevedo, N. F., Azevedo, A. S., Todorov, S. D., Ji, Y., Kang, H., & Holzapfel, W. H. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400494 · Cited by 1
Potential role of probiotics for neurological disease treatment
Quadri, K., Kadian, R., Thakur, S., Chaturvedi, S., Rawat, G., Waziri, A., & Alam, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00030-0 · Cited by 1
Laha, S., Katheeja Muhseena, N., Das, S. P., & Das, R. (2021) · Research Square · doi:10.21203/rs.3.rs-1084603/v1 · Cited by 1
Midya, V., Lane, J., Gennings, C., Torres-Olascoaga, L., Wright, R., Arora, M., Téllez‐Rojo, M., & Eggers, S. I. (2023) · medRxiv · doi:10.1101/2023.05.18.23290127 · Cited by 1
Microbiological Modification Therapy For Acute Medical Presentations Of Generalised Anxiety Disorder
Brzezicki, M. A., Celentano, L., Ostrowski, M., & Chakraborty, A. (2020) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.11.67
Gut Microbiota in Brain diseases
Salami, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00040-1
Francella, C., & Foster, J. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc297
Therapeutic applications of probiotics and its regulatory framework
Singh, K., Kaur, T., & Rao, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823966-7.00027-x
Han, S., Shin, Y.-J., Lee, D.-Y., Kim, K., Yang, S.-J., Kim, D. S., Choi, J.-W., Lee, S., & Kim, D.-H. (2020) · Research Square · doi:10.21203/rs.3.rs-112385/v1
Self-citationXu, K., Liu, L., Yin, J., He, Y., & Zhou, H. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0355
da Silva, G. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.58.2021.tde-29112022-171354
In-depth analysis benefital effect of probiotics and fatty acids in anesis of depressionPreprint
Gao, H., He, C., Xin, S., Hua, R., Du, Y., Wang, B., Gong, F., Yu, X., Pan, L., Gao, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2827753/v1
Tang, Y., Guo, Y., Xie, X., Chen, Y., Huang, X., Dai, D., & Wu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3448405/v1
Exploring the Microbiome through Probiotics and Psychobiotics: Deciphering the Gut-Brain Link
Pathak, R., Tirumalai, P. S., & Kashyap, S. (2023) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2023.06.1315 · Cited by 1
The microbiome mechanism behind depression and treatment prospects of targeting intestinal microbes
Jiang, K., Wang, H., Zeng, Z., Shi, X., Liu, L., Wu, G., & Tan, Y. (2025) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000421
Next-generation probiotics: Advancements in fermented dairy products and their health benefits
Ajmal, A., Yang, J., Ajmal, R., & Mahmud, M. Z. A. (2025) · Traditional Medicine and Modern Medicine · doi:10.1142/s2575900025300048
Han, S.-K., Shin, Y.-J., Lee, D.-Y., Kim, K. M., Yang, S.-J., Kim, D. S., Choi, J.-W., Lee, S., & Kim, D.-H. (2021) · Figshare · doi:10.6084/m9.figshare.14594226
Self-citationГурова, М. М. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-023
Metadata
- Authors
- Jang, H.-M., Lee, K.-E., & Kim, D.-H.
- Affiliations
- Kyung Hee University (KR)
- Corresponding author
- Kim, Dong-Hyun
- ORCID
- Kim, Dong-Hyun
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-04-11
- Volume
- 11
- Issue
- 4
- Pages
- 819
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6521032
- OpenAlex
- W2939407924
- Cited by
- 208
- References
- 50
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 31 · 2023: 37 · 2022: 33 · 2021: 35 · 2020: 19 · 2019: 8
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2017R1A5A2014768)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- probiotics, restraint stress, anxiety, depression, colitis, microbiota-gut-brain axis, gut dysbiosis, NF-κB activation, lipopolysaccharide, microglial activation, hippocampus, brain-derived neurotrophic factor, interleukin-6, corticosterone, Proteobacteria, gut immune response
- MeSH terms
- Bifidobacterium adolescentis, Animals, Anxiety, Cell Line, Colitis, Depression, Humans, Lipopolysaccharides, Male, Mice, Inbred C57BL, Neuroblastoma, Restraint, Physical, Stress, Psychological, Tumor Cells, Cultured, NF-kappa B, Microglia, Probiotics, Mice, Limosilactobacillus reuteri, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.